Pharmaceutical

Specialised Therapeutics partners with Treeway to license ALS drug

Specialised Therapeutics has entered into a licensing agreement with Treeway for TW001, designed for treating amyotrophic lateral sclerosis.

Aug 28, 2023 - 20:00
Specialised Therapeutics partners with Treeway to license ALS drug
Specialised Therapeutics has entered into a licensing agreement with Treeway for TW001, designed for treating amyotrophic lateral sclerosis.
Read the original article

Tags:

Previous Article

STAT+: Republican presidential candidates spar over abortion bans

Next Article

Phebra, University of Wollongong partner to develop cancer therapies

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

China NMPA approves Zai Lab-argenx’s efgartigimod alfa for gMG

China NMPA approves Zai Lab-argenx’s efgartigimod alfa ...

Jul 18, 2024

STAT+: Pharmalittle: China arrests an Astellas exec accused of spying; weight-loss drugs are being tested in children

STAT+: Pharmalittle: China arrests an Astellas exec acc...

Oct 20, 2023

Microbiome company Enterome plans $108m raise to fund Phase II cancer trials

Microbiome company Enterome plans $108m raise to fund P...

Aug 26, 2023